BMO Capital analyst Keith Bachman raised the firm’s price target on UiPath (PATH) to $15.50 from $11.50 and keeps a Market Perform rating on the shares. The company posted a solid Q1 against low expectations and raised guide for annual recurring revenue and revenue for the remainder of FY26 as highlighted by stronger deal pipeline, the analyst tells investors in a research note. UiPath management also struck a more optimistic tone around agentic momentum and public sector uncertainty, BMO added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH: